90
Participants
Start Date
February 7, 2024
Primary Completion Date
January 31, 2026
Study Completion Date
June 30, 2026
AK117
AK117 IV injection
Placebo
Placebo IV injection
Azacitidine
Azacitidine SC injection
RECRUITING
Montefiore Einstein Comprehensive Cancer Center, The Bronx
RECRUITING
American Oncology Partners, PA (The Center for Cancer and Blood Disorders-Bethesda), Bethesda
RECRUITING
Maryland Oncology-Columbia, Columbia
RECRUITING
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
RECRUITING
MUSC Hollings Cancer Center, Charleston
RECRUITING
Mid Florida Hematology and Oncology Center, Orange City
RECRUITING
Ohio State University, Columbus
RECRUITING
Gabrail Cancer Center, Canton
RECRUITING
Washington University School of Medicine in St. Louis, St Louis
RECRUITING
Rocky Mountain Cancer Centers, Aurora
RECRUITING
UCLA Ronald Reagan Medical Center, Los Angeles
RECRUITING
Oncology Associates of Oregon, Eugene
RECRUITING
Yale Cancer Center, New Haven
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
Institute of hematolongy&blood diseases hospital, chinese academy of medical sciences&peking union medical college, Tianjin
Lead Sponsor
Akeso
INDUSTRY